|Bid||56.13 x 800|
|Ask||56.14 x 900|
|Day's range||55.05 - 56.25|
|52-week range||51.72 - 82.15|
|Beta (3Y monthly)||1.05|
|PE ratio (TTM)||N/A|
|Earnings date||7 Aug 2019|
|Forward dividend & yield||2.00 (3.60%)|
|1y target est||67.05|
We study the impact of Trump's dropping of the proposed drug rebate rule on some health ETFs with exposure to pharmacy benefit managers and healthcare insurers.
The Trump administration announced Thursday that it's deciding to withdraw its proposal to eliminate rebates from government drug plans.
The drug companies provide rebates to PBMs in exchange for distributing their products.
CVS Health (CVS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
CVS will open HealthHUBs in Boston, Dallas-Forth Worth, Florida, Maryland, North Carolina, Ohio, and Virginia in the first half of 2020. HealthHUBs embody CVS's vision for the $70 billion acquisition of health insurer Aetna.
Insurers UnitedHealth, Cigna and CVS Health, which bought Aetna last year, are all up in early trading Thursday on the news.